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Dear Editor,
Measles is a highly infectious airborne acute 
viral disease. In some of the cases it is accom-
panied by severe complications, which may 
result in death, including pneumonia and en-
cephalitis. Each year more than 20 million people 
suffer from measles worldwide, predominantly 
in several parts of Africa and Asia, including the 
Eastern Mediterranean Region (EMR).1 Before 
the vaccination era, measles was widespread in the 
world. In the decade before the national measles 
vaccine program was implemented in the United 
States, it was estimated that about 4 million peo-
ple had contracted measles.2 Out of approximately 
500,000 measles cases reported annually, 500 
resulted in death and 1,000 in permanent brain 
damage due to measles encephalitis.2 
With the implementation of the routine mea-
sles immunization the incidence rate began to 
decrease progressively. This gave grounds to the 
World Health Organization (WHO) Regional Of-
fice for Europe to develop a program for the elimi-
nation of the disease.3 In Bulgaria, WHO case 
definitions and case classification of the European 
Union have been adopted since 2005.4-6
Despite the essential decrease of the morbidity 
in Europe in the last 4 years epidemic outbreaks of 
measles have been registered in many of the Euro-
pean countries: in France during 2008 – 604 cases;7 
in Ireland since August 2009-2010 – 320 cases;8 in 
Germany from March 15 until May 19, 2010 – 71 
cases;9 in Poland for 2009 – 40 cases.10 In Slovenia 
2 cases of measles as nosocomial infections were 
registered in March 2010.11 In Greece from January 
to July 2010, 126 cases were announced originally 
related to the outbreak in Bulgaria.12 In Italy dur-
ing the first six months of 2010, 19 cases were con-
firmed in a population with consistently high and 
improving immunization coverage.13 In Spain from 
October 13 to December 7, 2010, 59 patients with 
measles were registered.14 In northern Serbia 121 
cases were diagnosed with measles, 78 of which 
were laboratory-confirmed during 2007.15
In Bulgaria, measles immunization was intro-
duced in 196916,17 and in 1972 it became universal. 
Until 1982 the routine vaccination included one 
dose of measles vaccine administered in people 
≥ 10 months of age. During the period of 1983-
1992, a two-dose schedule using monovalent 
measles vaccine was applied, firstly at 12 months 
and 4 years of age, and later at 12 and 24 months of 
age. In 1993, the measles, mumps, rubella (MMR) 
vaccine was introduced into the national vaccina-
tion schedule. Until 2000, the routine measles im-
munization consisted of the first dose with MMR 
vaccine given at 13 months of age and the second 
dose with monovalent measles vaccine at 12 years 
of age. Since 2001, a routine two-dose immuniza-
tion with MMR vaccine has been implemented, 
administered at 13 months and 12 years of age.
The last indigenous cases of measles in Bul-
garia were reported in 2001.17,18 From 2002 to 
2008, only six measles cases have been regis-
tered, all of them imported: three from China 
(2005); one from Ukraine (2006); one from Ger-
many (2007) and one from the United Kingdom 
(2008).19,20 After seven years without indigenous 
transmission of measles in Bulgaria, an increasing 
number of cases have been reported since April 
15 2009. The epidemiological investigation re-
vealed that the index case was imported in March 
of the same year from Germany. The patient, a 
24-year-old man, became ill on March 12, four 
days after arrival from Hamburg, where he used 
to work.17 The subsequent three measles cases 
occurred among his close contacts (fam-
ily members). They were laboratory-confirmed 
by the National Reference Laboratory in So-
fia. The samples were then sent to the WHO 
Regional Reference Laboratory (RRL) for 
Measles and Rubella in Berlin for reconfirmation 
and measles virus (MV) genotyping. The nucleo-
tide sequences of the variable part of measles virus 
N gene (450 nt) derived from these three cases 
were identical and classified as genotype D4. Their 
sequence is represented by the official WHO Este é um artigo Open Access sob
 a licença de CC BY-NC-ND
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name MVs/Shumen.BGR/15.09/1(D4).17 Over the next few 
months of 2009 many indigenous cases of measles occurred 
and the outbreak covered the whole country.
The aim of the study was to analyze the epidemiologi-
cal characteristics of the patients with measles treated in the 
Clinics of Infectious Diseases – University Hospital, Plovdiv 
during the first six months of 2010.
METHODS
Measles is included in the notification system of infectious 
diseases in Bulgaria and any suspected measles case re-
quires obligatory immediate notification (within 24 hours) 
by fax or phone from health centers, clinical settings or 
hospitals to the Regional Inspection for Prevention and Con-
trol of Public Health (RIPCPH).6 Notifications of measles 
cases are collected and analyzed nationally at the National 
Center for Infectious and Parasitic Diseases (NCIPD) in 
the Ministry of Health of Bulgaria. Measles cases are identi-
fied and classified using standard case definitions and case 
classifications.4,5 A confirmed case of measles is either labora-
tory confirmed or epidemiologically linked to a patient with 
laboratory-confirmed measles infection.5 In Bulgaria, an 
outbreak of measles is defined as a chain of transmission with 
3 or more confirmed cases. During the outbreak in Plovdiv in 
2010, 417 (15%) of all the cases were laboratory-confirmed by 
the National Reference Laboratory in Sofia and 876 (32%) were 
linked epidemiologically with them. The laboratory confirma-
tion was done through positive serological test for measles-spe-
cific IgM. The other cases (1481 - 53%) were notified as probable. 
There was no practical opportunity for laboratory confirmation 
of those cases, as the epidemic situation expanded considerably 
and more than 15 cases were registered daily (sometimes reach-
ing up to 40 a day) only in Plovdiv. These patients were diag-
nosed based on clinically manifested symptoms: fever (raised 
temperature of 38.3oC or higher), illness with generalized mac-
ulo-papular rash of 3 days duration or more, and cough, coryza, 
or conjunctivitis. All cases with complications (pneumonia or 
neurological symptoms) and those with atypical manifestation 
of clinical symptoms were laboratory confirmed.
Surveillance data for the studied patients include patients’ 
household location, age, sex, ethnicity, measles vaccination sta-
tus, history of contact with another measles case, date of rash 
appearance, date of patient’s visit at health setting, date of inves-
tigation at patient’s home, date of notification to the RIPCPH. 
Vaccination status of the cases was determined by parental or 
patient report and/or by review of the immunization card. The 
cases aged 14 months to 12 years were considered unvaccinated 
if they had not received the first dose MMR at 13 months and 
the patients older than 12 years – in cases in which they had 
received neither the second dose at 12 years nor both of the 
doses (respectively 13 months and 12 years). 
We analyzed all patients with measles, hospitalized in the 
Clinics of Infectious Diseases – University Hospital, Plovdiv 
in 2010 after having received their informed consent.
RESULTS
In Bulgaria, a total of 21,984 cases of measles have been re-
ported in 2010, and the cases from Plovdiv region were 2,774 
(Figure 1). The incidence rate for the country was 289/100,000 
and for Plovdiv – 392/100,000. 
From the patients in Plovdiv, 1,428 (51.5%) were male. 
The incidence rate for male was 421/100,000 and for female 
– 368/100,000. A total of 1,901 (69%) of the patients in Plov-
div were hospitalized in the Clinics for Infectious Diseases 
– Medical University, Plovdiv. The median age of the hospital-
ized patients was 8 years (range 4 months to 63 years of age).
The distribution of the patients by months from January 
to June 2010 shows the dynamics of the outbreak. It began 
relatively smoothly with few cases during January and Febru-
ary (respectively 1.4% and 3.6% of all cases). They increased 
essentially in March (12.7%) and reached their maximum 
in April (34.3%) and May (29.3%). In June a great decrease 
of the measles-cases was notified (18.6%) and subsidence of 
the outbreak. During the following days (up to the middle 
of August) a few cases were registered, a total of 41.
Most of the patients were hospitalized on epidemio-
logical evidence, since most of them were representa-
tives of the Roma ethnic group, who live in overpopulated 
households in bad hygienic conditions, and have more than 
3 children. One of the hospitalized patients died (aged 4 
months, with pneumonia) and 27 have been treated in the 
intensive care sector. 
The analysis of the age distribution disclosed that the 
number of patients is the highest among children aged 13 
months to 12 years (51%).
This is the age group which includes the period from the 
vaccination with the first dose MMR (at 13 months) to 
the administration of the second dose (at 12 years). It was followed 
by the cases of infants aged 4 weeks to 13 months (27%). The dis-
eased from the elder age groups were in smaller numbers, respec-
tively: 13-18 years (11%), 19-35 years (9%), > 35 years (3%). 
The age distribution by months did not show deviation 
from the age distribution of the case-patients for the whole 
period of the outbreak. There was no shifting of incidence of 
cases from one group to another. 
Figure 1: Registered measles cases by weeks in Bulgaria and 
Plovdiv – 2010.
Bulgaria
Plovdiv
1600
1400
1200
1000
800
600
400
200
0
1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51
Reemergence of measles in Bulgaria: a large outbreak in Plovdiv, 2010 
615Braz J Infect Dis 2011; 15(6):613-616
Vatev, Stoycheva, Petrov
Most of the cases (59%) occurred in individuals living in 
cities – probably due to the greater population density in cit-
ies which intensifies the epidemic process. 
Significant difference was established between the 
occurrence of cases in the Roma population (95.07%) and 
the Bulgarians (4.93%). There were also significant differ-
ences in the age structure of both patient groups. Patients 
aged 13 months to 12 years (49%) and infants (28%) prevailed 
among Roma cases while among Bulgarians about 80% of the 
cases were above 18 years of age.
Most of the cases (65%) were epidemiologically linked to 
another patient with measles and in 35% the initial case was 
not identified. 
For 2/3 of the cases (64%) isolation was timely – on the 
first day after rash eruption or even during the last days of 
the catarrhal period. Cases of late isolation were not few in 
number (36%) – they were isolated on the second or third day 
after rash eruption. The main reason for the delay was tardy 
seeking of medical attention and in some of the cases – delay 
in the transfer of patients from other clinics. 
The study of the vaccination status (Table 1) showed that 
33% of the patients had been vaccinated. Of the total of 892 
patients aged 16 months to 12 years, 530 (59%) were vaccinat-
ed. The percent of the vaccinated patients from the age group 
13-18 years was 32%.
DISCUSSION
With the increasing vaccination coverage resulting from com-
pulsory measles vaccination in 1972, the incidence of measles 
in Bulgaria was significantly reduced since 1977. However, re-
surgences occurred in 1981-1982 and 1992. The resurgence in 
1992 was attributed to lack of a second dose MMR at 12 years 
of age which was introduced at the end of 1992.16 The last re-
surgence began in April 2009. Until the end of 2010 a total 
of 24,233 cases had been notified with 24 deaths. The rapid 
resurgence could possibly be attributed to an accumulation 
of susceptible individuals (non-immune) to a critical thresh-
old level. The outbreak arose in the Northeastern part of the 
country and gradually spread to all regions. From the noti-
fied cases for 2010 about 30,000 measles cases in Europe,21 the 
largest number was from Bulgaria – 21,766 (over 70%). This 
large outbreak occurred while the data of NCIPD for the vac-
cination coverage against measles in Bulgaria was as follow: 
2005: 1st dose – 96%, 2nd dose – 92%; 2006: 1st dose -96%, 2nd 
dose -93%; 2007: 1st dose -96%, 2nd dose – 94%; 2008: 1st dose 
-96%, 2nd dose -94%.17 The magnitude of the epidemic and 
the vaccination coverage showed discrepancy with the world 
practice for surveillance of the disease. According to practice 
with an immunization coverage of > 95%, the outbreak of 
such a serious epidemic, that covers the whole country and 
the morbidity in 2010 reached 289/100,000 while in some re-
gions it was above 600/100,000, is impossible. This is probably 
due to improper recording and reporting of immunizations. 
This fact makes the surveillance of the disease difficult and 
can fully compromise the adopted National Program for the 
elimination of measles6 – what actually happened in practice. 
Measles is not only a preventable disease, it is also predictable. 
If the immunization coverage is recorded accurately, timely 
measures can be taken. When the immunization coverage is 
low, an additional vaccination campaign can be carried out 
before an epidemic outbreak.
The demographic characteristics of the cases show that 
measles is registered in over 95% among persons of Roma ori-
gin. While studies from other countries22 revealed that a con-
siderable part (21%) of the measles cases were among foreign 
visitors or imported from neighbor countries23 in Bulgaria the 
main risk group is the Roma population. The cause is the low 
vaccination coverage among them because of the intensive 
migration and the low health culture. 
The analysis of the age distribution established high 
level (7%) of the cases for patients aged < 6 months. This is 
not in consonance with the data from other authors22,24 ac-
cording to whom the relative part of the cases at this age is 
1-4%. Cases of measles among children < 6 months are due 
to non-transmitted immunity from the mother to the child. 
Most of the mothers (> 90%) from the Roma population are 
Table 1. Vaccination coverage of the patients*
Age group Unvaccinated Vaccinated Unknown vaccination status All
< 6 months 139 (100) 0 0 139 (7)
6-13 months 375 (100) 0 0 375 (20)
14-16 months 58 (79) 7 (10) 8 (11) 73 (4)
17 months to 5 years 91 (29) 190 (61) 32 (10) 313 (16)
6-12 years 103 (18) 342 (59) 134 (23) 579 (30)
13-18 years 78 (39) 65 (32) 59 (29) 202 (11)
19-35 years 41 (25) 28 (17) 93 (58) 162 (9)
> 35 years 43 (74) 0 15 (26) 58 (3)
Total 928 (49) 632 (33) 341 (18) 1901
*Data cover number of cases in age group (% of age group with the vaccination status specified) or the total number of cases (% 
of total for age group), unless otherwise indicated.
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aged 15-25 years. This implicitly means that in this age group 
there is also a pocket of non-vaccinated people. The part 
of the cases from 14 months to 12 years is too high – 51%. 
The diseases at this age are due to omission of the 1st MMR 
dose at 13 months. Additionally, the cause for the high num-
ber of cases among people aged 13-18 years (11%) is omission 
of 2nd MMR (or 1st and 2nd) dose(s) at the age of 12 years.
Our observation on the proportion of measles cases in people 
over 19 years is not in agreement with previous reports that pointed 
out an age shift in measles incidence to older susceptible individu-
als.25,26 The percentage of cases over 19 years in our study is 12% but 
this shift of measles infection to adults is also disturbing as it has 
serious consequences for children. Infected adults could transmit 
measles virus to susceptible children. What is more, susceptible 
mothers cannot transmit protective anti-measles virus antibod-
ies to newborn children, thus leaving them vulnerable to possible 
measles infection from their parents or other close contacts.
CONCLUSION 
To prevent further outbreaks, surveillance should be enhanced to 
achieve complete coverage as well as consideration of older age 
group to avoid accumulation of susceptible persons. It is neces-
sary to identify the areas with inadequate immunization perfor-
mance, build up awareness among the hard-to-reach population 
to promote their vaccine-seeking behavior, repeat measles vac-
cination campaign to cover all children, conduct further com-
munity-based studies to identify the immunological status and 
reasons of vaccine failure. In addition, measles “catch-up” immu-
nization campaigns should be conducted in Bulgaria to interrupt 
chains of transmission. Furthermore, the duration of impact of 
campaigns should not exceed 4-5 years, even in best circumstanc-
es of high routine coverage. Implementing these measures among 
the Roma population in Bulgaria is of great importance because 
the routine immunization among these people is often compro-
mised. Milestone for the elimination of measles is to achieve 
> 95% vaccination coverage with 2 doses MMR, but it has to be 
actual and not only existing on paper. 
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